Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome

REFERENCES

• Holmes G, Kaplan J, Gantz Net al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387–389.
   PubMed Web of Science ®Google Scholar
• Sharpe MC, Archard LC, Banatvala JE et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118–121.
   PubMed Web of Science ®Google Scholar
• Swartz MN. The chronic fatigue syndrome - one entity or many? N Engl J Med 1988; 319: 1726-1728.
   Google Scholar
• Richards RS, Roberts TK, Mathers D, Dunstan RH, McGregor NR, Butt BL. Erythrocyte morphology in rheumatoid arthritis and chronic fatigue syndrome: a preliminary study. J Chronic Fatigue Syrzd 2000: In press.
   Google Scholar
• Richards RS, Roberts TK, Mathers D, Dunstan RH, McGregor NR, Butt BL. Investigation of erythrocyte oxidative damage in rheumatoid arthritis and chronic fatigue syndrome. J Chronic Fatigue Syrzd 2000: In press.
   Google Scholar
• Roberts TK, McGregor NR, Dunstan RH et al. Immunological and haematological parameters in patients with chronic fatigue syndrome. J Chronic Fatigue Synd 1998; 4: 51–65.
   Google Scholar
• McGregor NR, Dunstan RH, Zerbes M, Butt BL, Roberts TK, Klineberg U. Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome. Biochem Mol Med 1996; 58: 85–92.
   PubMedGoogle Scholar
• Jaffe ER. Methaemoglobin pathophysiology. Prog Clin Biol Res 1981; 51: 133–151.
   PubMedGoogle Scholar
• Clopton DA, Saltman P. Copper-specific damage in human erythrocytes exposed to oxidative stress. Biol Trace Elem Res 1997; 56: 231–240.
   PubMed Web of Science ®Google Scholar
• Dotsch J, Demirakca S, Cryer A, Hanze J, Kuhl PG, Rascher W. Reduction of NO-induced methaemoglobinemia requires extremely high doses of ascorbic acid in vitro. Intensive Care Med 1998; 24: 612–615.
   PubMed Web of Science ®Google Scholar
• Kaca W, Roth RI, Vangegriff KD et al. Effects of bacterial endotoxin on human cross-linked and native haemoglobins. Biochemistry 1995; 34: 11176–11185.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Coleman MD, Hussain F, Breckenridge AM, Park BK. Direct and metabolism dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. Br J Clin Pharmacol 1991; 320: 303–310.
   Web of Science ®Google Scholar
• Sullivan SG, Stern A. Effects of physiologic concentrations of lactate, pyruvate and ascorbate on glucose metabolism in unstressed and oxidatively stressed human red blood cells. Biochem Pharmacol 1983; 32: 2891–2902.
   PubMed Web of Science ®Google Scholar
• Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt BL. The role of erythrocytes in the inactivation of free radicals. Med Hypotheses 1998; 50: 363–367.
   PubMed Web of Science ®Google Scholar
• Cleary KJ, White PD. Gilbert's and chronic fatigue syndromes in men. Lancet 1993; 341: 842.
   PubMed Web of Science ®Google Scholar
• Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM. Nuclear localisation of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 1998; 53: 701–707.
   PubMed Web of Science ®Google Scholar
• Sunaga K, Takahashi H, Chuang DM, Ishitani R. Glyceraldehyde-3-phosphate dehydrogenase is overexpressed during apoptotic death of neuronal cultures and is recognised by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci Lett 1995; 200: 133–136.
   PubMed Web of Science ®Google Scholar
• Hawkins RA, Sangster K, Arends MJ. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 1998; 185: 61–70.
   PubMed Web of Science ®Google Scholar
• Vojdani A, Ghoneum M, Choppa PC, Magtoto L, Lapp CW. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Intern Med 1997; 242: 465–478.
   PubMed Web of Science ®Google Scholar
• Chao CC, Janoff EN, Hu SX et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 3: 292–298.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Sirr SA, Grammith FC et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Diagn Lab Immunol 1994; 1: 222–226.
   PubMedGoogle Scholar
• Bennett AL, Chao CC, Hu S et al. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160–166.
   PubMed Web of Science ®Google Scholar
• Houglum K, Ramm GA, Crawford DH, Witztum JL, Powell LW, Chojkier M. Excess iron induces hepatic oxidative stress and transforming growth factor-beta 1 in genetic hemochromatosis. Hepatology 1997; 26: 605–610.
   PubMed Web of Science ®Google Scholar
• Islam KN, Kayanoki Y, Kaneto H et al. TGF-beta 1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radic Biol Med 1997; 22: 1007–1017.
   PubMed Web of Science ®Google Scholar
• Simpson LO, Murdoch JC, Herbison GP. Red cell shape changes following trigger finger fatigue in subjects with chronic tiredness and healthy controls. N Z Med J 1993; 106: 104–107.
   PubMed Web of Science ®Google Scholar
• Mukherjee T, Smith K, Maros K. Abnormal red blood cell morphology in myalgic encephalomyelitis. Lancet 1987; 11 328-329.
   Google Scholar
• van Asbeck S, Hoidal J, Schwartz B„ Vercellotti GM, Moldow CF, Jacob HS. Insufflated red cells protect lungs from hyperoxic damage: role of red cell glutathione in scavenging toxic 02 radicals. Trans Assoc Am Physicians 1984; 97: 365–368.
   PubMedGoogle Scholar
• Zachee P, Emonds MP, Lins R, Boogaerts M. Red blood cells, the scavengers for toxic free radicals during haemodialysis [letter]. Nephrol Dial Transplant 1988; 3: 104–105.
   PubMedGoogle Scholar
• Winterbourn CC, Stern A. Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J Clin Invest 1987; 80: 1486–1491.
   PubMed Web of Science ®Google Scholar
• Toth KM, Clifford DP, Berger EM, White CW, Repine JE. Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J Clin Invest 1984; 74: 292–295.
   PubMed Web of Science ®Google Scholar
• Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage. Biochem Mol Biol Int 1998; 46: 857–865.
   PubMedGoogle Scholar
• Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. Erythrocytes protect cultured endothelial cells from neutrophil-mediated damage. Aust J Med Sci 1997; 18:73–77.
   Google Scholar
• Agar NS, Sadrzadeh SM, Holloway PE, Eaton JW. Erythrocyte catalase. A somatic oxidant defense? J Clin Invest 1986; 77: 319–321.
   PubMed Web of Science ®Google Scholar